An astroglial basis of major depressive disorder? An overview
- 20 March 2017
- Vol. 65 (8), 1227-1250
- https://doi.org/10.1002/glia.23143
Abstract
Depression is a chronic, recurring, and serious mood disorder that afflicts up to 20% of the global population. The monoamine hypothesis has dominated our understanding of the pharmacotherapy of depression for more than half a century; however, our understanding of the pathophysiology and pathogenesis of major depression has lagged far behind. Astrocytes are the most abundant and versatile cells in the brain, participating in most, if not all, of brain functions as both a passive housekeeper and an active player. Mounting evidence from clinical, preclinical and post-mortem studies has revealed a decrease in the number or density of astrocytes and morphological and functional astroglial atrophy in patients with major depressive disorder (MDD) and in animal models of depression. Furthermore, currently available antidepressant treatments at least partially exert their therapeutic effects on astrocytes. More importantly, dysfunctional astrocytes lead to depressive-like phenotypes in animals. Together, current studies point to astroglial pathology as the potential root cause of MDD. Thus, a shift from a neuron-centric to an astrocyte-centric cause of MDD has gained increasing attention during the past two decades. Here we will summarize the current evidence supporting the hypothesis that MDD is a disease of astrocyte pathology and highlight previous studies on promising strategies that directly target astrocytes for the development of novel antidepressant treatments.Keywords
Funding Information
- National Natural Science Foundation of China (81329003, 31430032, 81671356, U1201225)
This publication has 102 references indexed in Scilit:
- 1H-[13C]-Nuclear Magnetic Resonance Spectroscopy Measures of Ketamine's Effect on Amino Acid Neurotransmitter MetabolismBiological Psychiatry, 2012
- Chronic psychosocial stress and citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampusPsychopharmacology, 2012
- Heterogeneity of Astrocytic Form and FunctionMethods in molecular biology (Clifton, N.J.), 2011
- Antidepressant-like properties of oral riluzole and utility of incentive disengagement models of depression in micePsychopharmacology, 2011
- Postsynaptic BDNF‐TrkB signaling in synapse maturation, plasticity, and diseaseDevelopmental Neurobiology, 2010
- Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survivalJournal of Biological Physics, 2009
- Neuropeptides in depression: Role of VGFBehavioural Brain Research, 2009
- Glial Loss in the Prefrontal Cortex Is Sufficient to Induce Depressive-like BehaviorsBiological Psychiatry, 2008
- Identification of Positionally Distinct Astrocyte Subtypes whose Identities Are Specified by a Homeodomain CodeCell, 2008
- Effects of chronic unpredictable stress and methamphetamine on hippocampal glutamate functionBrain Research, 2007